Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma

Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma

Background: Survival after surgery for pancreatic ductal adenocarcinoma (PDAC) remains poor. Thus, novel therapeutic concepts focus on the development of targeted therapies. In this context, inhibitor of apoptosis protein (IAP) survivin is regarded as a promising oncotherapeutic target. However, its...

Full description

Bibliographic Details
Main Authors: Christian Vay, Shahrooz Babaei, Sami-Alexander Safi, Levent Dizdar, Alexander Rehders, Lena Haeberle, Christoph Roderburg, Sven H. Loosen, Irene Esposito, Wolfram T. Knoefel, Andreas Krieg
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
survivin
BIRC5
inhibitor of apoptosis protein family
IAP
ductal adenocarcinoma of the pancreas
PDAC
Online Access:https://www.mdpi.com/2072-6694/14/14/3494

Internet

https://www.mdpi.com/2072-6694/14/14/3494

Similar Items